WebAlbireo Pharma Inc. company facts, information and financial ratios from MarketWatch. Skip to main contentMain Menu Home Latest News Watchlist Market Data Center U.S. Cryptocurrency Europe... WebPresident and Chief Executive Officer Ron Cooper, Albireo’s first President and CEO, is a global P&L leader with a track record of growing businesses, brands and organizations in the U.S. and Europe.
Did you know?
WebMar 21, 2024 · Albireo Pharma, Inc. announced the appointment of Pamela Stephenson, MPH, as Chief Commercial Officer, effective March 25, 2024. In the newly created leadership position, Stephenson will be... February 27, 2024 WebJan 23, 2024 · Within the last three months, Pamela Stephenson has sold $4,467.60 in shares of Albireo Pharma stock. Most recently, Pamela Stephenson sold 102 shares of …
WebJul 25, 2024 · The estimated Net Worth of Pamela Stephenson is at least $2.91 millió dollars as of 22 July 2024. Ms. Stephenson owns over 106 units of Albireo Pharma Inc stock worth over $770,087 and over the last 4 years she sold ALBO stock worth over $172,927. In addition, she makes $1,963,390 as Chief Commercial Officer at Albireo … WebMar 21, 2024 · Albireo Expands Executive Leadership Team with Appointment of Pamela Stephenson as Chief Commercial Officer. March 21, 2024, 12:30 PM UTC. Share this article. Copied
WebPamela Stephenson, Albireo Pharma Inc: Profile and Biography - Bloomberg Markets Bloomberg Bloomberg Anywhere Remote Login Software Updates Manage Products … WebPamela Stephenson was appointed as a member of the Board of Directors in February 2024. Ms. Stephenson has more than 20 years of experience leading the development and implementation of pharmaceutical marketing plans. Since March 2024, Ms. Stephenson has served as a chief commercial officer for Albireo Pharma, Inc., a publicly-traded …
WebEarlier in his career, he spent 20 years at Eli Lilly and Company in numerous senior leadership roles in the U.S. and Europe including Head of Investor Relations, European …
WebGet Pamela Stephenson's email address (p*****@albireopharma.com) and phone number (917-328-....) at RocketReach. Get 5 free searches. Rocketreach finds email, phone & social media for 450M+ professionals. tata programma tvWebMar 21, 2024 · BOSTON, March 21, 2024 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the appointment of Pamela Stephenson, MPH, as Chief Commercial Officer, effective March 25, 2024. tata programujeWebMar 2, 2024 · Albireo Pharma, Inc's most recent insider trade came on January 23, 2024 by Pamela Stephenson who sold 102 units worth $4.47K . In the last 6 years, insiders at Albireo Pharma, Inc have... bateman wvWebJul 25, 2024 · The estimated Net Worth of Pamela Stephenson is at least $2.97 Milion dollars as of 22 July 2024. Ms. Stephenson owns over 106 units of Albireo Pharma Inc stock worth over $836,610 and over the last 4 years she sold ALBO stock worth over $172,927. In addition, she makes $1,963,390 as Chief Commercial Officer at Albireo … tata programokWebMar 2, 2024 · Albireo Pharma, Inc's most recent insider trade came on January 23, 2024 by Pamela Stephenson who sold 102 units worth $4.47K . In the last 6 years, insiders at … batemaruWebDec 1, 2024 · Albireo Pharma Inc executives and other stock owners filed with the SEC include: Ronald Cooper, President, Chief Executive Officer, Director Pamela Stephenson, Chief Commercial Officer Jan Mattsson, Chief Scientific Officer Martha Carter, Chief Regulatory Officer Ronald H. W. Cooper, CEO, Pres & Director Patrick Horn, Chief … tata prima 3530.kWebMar 21, 2024 · -- Significant recent rare disease product launch and access experience -- -- Key addition as Albireo prepares for commercialization of A4250 -- Albireo Pharma, bateman y snell 2009 pdf